Report me for selling fake medicine? Why are you crying when your illness relapses?

It is also difficult for them to come up with $3000 billion in cash.

"Chen Xuan is a really interesting person."

"First, we had a battle with Pfizer, and now it has escalated to a lawsuit."

"Now they're going up against Johnson & Johnson, AbbVie, and Mosadone again, using $3000 billion to eliminate them. What a brilliant idea!"

After feeling relieved, Anna looked towards the east and muttered with interest.

That's right, she believed that the reason why Chen Xuan offered a price of 3000 billion US dollars was to scare off Johnson & Johnson, AbbVie, and Mosadone.

The reason for this price is not that he thinks Antai Pharmaceutical Group is worth so much money, but that he does not want to sell Antai Pharmaceutical Group, so he deliberately offers such a sky-high price so that the other party will give up.

So, this made Anna feel very interesting.

Now she is becoming more and more curious about what Chen Xuan is pursuing.

Although he is not a businessman, he is indeed focused on making money.

But if he is a businessman, many of his behaviors are inconsistent with those of a businessman, and even go against the grain of a businessman.

In short, in Anna's eyes, Chen Xuan is a very contradictory combination. Perhaps she has not seen through his essence yet, so she doesn't know what kind of person he is.

"Chen Xuan has a new medicine."

"The new drug he told me about earlier has been successful. The speed of its development is truly outrageous!"

"And I was right. He has more than one new drug project, and he succeeded in two at once. That's terrifying."

Anna suddenly thought of this again.

She was more shocked by the success of Chen Xuan's new drug project than the $3000 billion acquisition.

Chen Xuan's speed in developing new drugs is simply abnormal.

Novartis invests tens of billions of dollars in research and development every year, and has countless top scientific researchers, but its achievements cannot be compared with those of Chen Xuan alone.

It's not just the quantity, the quality is also very different.

Every medical achievement of Chen Xuan is a world-class medical achievement, which is far beyond the reach of Novartis.

Touching her chin, Anna rolled her eyes and suddenly had an idea in her mind.

Chen Xuan's new drug research was successful, and she had to take action.

……

Anna is not the only one paying attention to this matter.

Almost everyone in the pharmaceutical industry around the world is paying attention to this matter.

Qin Guoming and others were so jealous that their hair turned purple.

As for the people who were directly affected by this incident, it is naturally Mosatrol, AbbVie, and Johnson & Johnson.

After Chen Xuan quoted the price, the stocks of the three giants, which had originally risen slightly, suddenly fell back, and even fell lower than before.

But faced with this situation, the three companies did not respond, as if they were just spectators.

……

……

The uproar in the outside world had little impact on Chen Xuan.

Go back to rest normally, and then return to work in the group.

There are a lot of things waiting for him, and he has no time to pay attention to those rumors.

As for the reactions of those pharmaceutical giants, that was also not within his scope of concern.

He is sorting some important things in the office now.

"Mr. Chen!"

"Ms. Avril from Xueguang Group is here."

At this time, Alyssa walked in with high heels and said.

Chen Xuan looked up at the foreign girl and was a little speechless when he saw her serious expression.

She acted so serious at this time that people who didn't know her would think she was a serious person.

"Let her in!" Chen Xuan smiled and shook his head.

The reason he was in the office was actually to wait for Avril to arrive.

A moment later, Avril also walked in.

"Mr. Chen, I wonder what you want to talk to me about? Do you have any doubts about our cooperation?"

After coming in, Avril asked directly.

She didn't know what Chen Xuan wanted to talk to her about, and she was even a little nervous.

"It has nothing to do with the previous cooperation. Take a look at these devices first."